Azithromycin Combination Therapy for the Treatment of Severe Malaria
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to assess the safety and efficacy of azithromycin combination
therapy for use in severe malaria. This pilot trial will be conducted in uncomplicated
malaria patients in southeastern Bangladesh.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of Vienna
Collaborator:
International Centre for Diarrhoeal Disease Research, Bangladesh